A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

NCT04008186 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

DRUG: Omaveloxolone
DRUG: Midazolam oral solution
DRUG: Repaglinide 1 MG
DRUG: MetFORMIN 500 Mg Oral Tablet
DRUG: Rosuvastatin
DRUG: Digoxin tablet
DRUG: Gemfibrozil Tablets
DRUG: Itraconazole capsule
DRUG: Verapamil Pill

Sponsor

Biogen

Collaborators

[object Object]